Lorenz Studer
Studer, Lorenz
VIAF ID: 288466444 (Personal)
Permalink: http://viaf.org/viaf/288466444
Preferred Forms
- 100 0 _ ‡a Lorenz Studer
- 100 1 _ ‡a Studer, Lorenz
- 100 1 _ ‡a Studer, Lorenz
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction | |
The epichaperome is an integrated chaperome network that facilitates tumour survival | |
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 | |
Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells | |
Excessive mobility interrupted | |
The expanding role of miR-302-367 in pluripotency and reprogramming. | |
Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent | |
Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons. | |
Functional Connectivity under Optogenetic Control Allows Modeling of Human Neuromuscular Disease. | |
G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson's disease | |
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response | |
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells | |
High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain. | |
A hPSC-based platform to discover gene-environment interactions that impact human β-cell and dopamine neuron survival | |
HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons | |
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage | |
Human iPSC-based modeling of late-onset disease via progerin-induced aging | |
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination | |
Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis | |
Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment | |
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells | |
Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection. | |
Induced pluripotent stem cell technology for the study of human disease. | |
IPSCs put to the test | |
Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. | |
Lessons Learned from Pioneering Neural Stem Cell Studies | |
Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs | |
Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon | |
Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons | |
Making and repairing the mammalian brain--in vitro production of dopaminergic neurons. | |
A mathematical model for the estimation of human embryonic and fetal age. | |
Mechanics-guided embryonic patterning of neuroectoderm tissue from human pluripotent stem cells | |
Mesenchymal cells | |
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration | |
miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. | |
Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs | |
Modelling familial dysautonomia in human induced pluripotent stem cells | |
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | |
Moving stem cells to the clinic: potential and limitations for brain repair | |
Neural Crest Cells from Dual SMAD Inhibition. | |
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. | |
Neural transplantation for the treatment of Parkinson's disease | |
NGF increases neuritic complexity of cholinergic interneurons in organotypic cultures of neonatal rat striatum. | |
Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. | |
Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model | |
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation | |
Parthenogenetic stem cells in nonhuman primates. | |
Pluripotent stem cell-based disease modeling: current hurdles and future promise | |
Pluripotent stem cells in regenerative medicine: challenges and recent progress | |
A Poised Chromatin Platform for TGF-β Access to Master Regulators | |
The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells | |
Production of green fluorescent protein transgenic embryonic stem cells using the GENSAT bacterial artificial chromosome library | |
Prospective isolation of cortical interneuron precursors from mouse embryonic stem cells | |
Retinoic Acid-Mediated Regulation of GLI3 Enables Efficient Motoneuron Derivation from Human ESCs in the Absence of Extrinsic SHH Activation | |
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines | |
Single-molecule analysis reveals changes in the DNA replication program for the POU5F1 locus upon human embryonic stem cell differentiation. | |
Specification of functional cranial placode derivatives from human pluripotent stem cells | |
Specification of positional identity in forebrain organoids | |
Stem cells with brainpower. | |
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation | |
Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial | |
Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors | |
TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency | |
Therapeutic cloning in individual parkinsonian mice | |
Too much Sonic, too few neurons. | |
Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. | |
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. | |
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling | |
When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease | |
Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells | |
ZFX controls the self-renewal of human embryonic stem cells | |
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models |